Sustained type of combined drugs require bio-equivalent test.

Published: 2004-09-24 06:58:00

Updated: 2004-09-24 06:58:00

The KFDA and KPMA took an explanatory meeting for the bio-equivalent test at the KPMA auditorium, the 4th floor of KPMA office building at 3 p.m. on Sept. 20 over the subject on the revised bill draft of "Standards for the Bio-equivalent Test", covering that any non-prescription drugs required th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK